SVA 0.00% 1.7¢ simavita limited

News: Simavita Limited banks $1.37M research and development tax refund

  1. Medical device company Simavita Limited (ASX:SVA, CVE:SV) has received a $1.37 million tax refund under the Australian Government’s Research and Development Tax Incentive Scheme.

    This is up from the provisional estimate of $1.2 million included in its financial statements for the year ended 30th June 2014.

    The company has developed a world first solution for the management of urinary incontinence, with a focus on the elderly.

    The SIM platform is a wireless sensor technology that provides evidence based incontinence management care plans to the residential aged care market.

    In January, Simavita signed up a Danish distributor for SIM under an exclusive, five-year agreement.

    The company’s cash balance was $4.9 million as at 31st December 2014.


GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.